Crinetics Pharmaceuticals, Inc.

UBS Group AG CRNX
Report date
12/31/2025
Quarter
2025 Q4
Filed
1/29/2026
Shares
908,192
Value ($000)
42,276
Weight
0.0%
2019 Q4 - 2025 Q4 (23 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).